Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely cont...
Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background
Human urothelial carcinoma (UC) has a high tendency to recur and progress to life-threatening advanced diseases. Advanced therapeutic regimens are needed to control UC development and recurrence.
Methods
We pursued in vitro and in vivo studies to understand the ability of a triple combination of gemcitabine, romidepsin, and cisp...
Alternative Titles
Full title
Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7374627
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7374627
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/s41416-020-0877-8
